Erik Schrumpf

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.

Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells.

Journal: Clinical and experimental immunology

Published: August 23, 2020

Natural killer T cells mediate inflammation in the bile ducts.

Natural killer T cells mediate inflammation in the bile ducts.

Journal: Mucosal immunology

Published: November 14, 2017

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.

Journal: Journal of hepatology

Published: December 21, 2016

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.

Journal: Gut

Published: December 15, 2016

Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.

Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: June 23, 2016

Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.

Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.

Journal: Journal of hepatology

Published: May 11, 2016

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.

Journal: Gastroenterology

Published: April 24, 2016

The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.

The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.

Journal: Gut

Published: August 04, 2015

Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway.

Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway.

Journal: Transplantation direct

Published: June 23, 2015

Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.

Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.

Journal: Hepatology (Baltimore, Md.)

Published: May 16, 2015

Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013.

Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013.

Journal: Scandinavian journal of gastroenterology

Published: May 12, 2015

Primary sclerosing cholangitis - the Norwegian experience.

Primary sclerosing cholangitis - the Norwegian experience.

Journal: Scandinavian journal of gastroenterology

Published: April 14, 2015

Showing 1-12 of 23

Last Updated: 09/26/2026